Биржевая цена
26.67
Изменение за день
0.41 1.56%
Ежемесячно
-5.02%
Ежегодный
11.45%
Q2 прогноз
26.42




Активы Изменить Дата
AbbVie USD 133.96B 62M 2025-12
Abbott USD 110.43B 23.72B 2026-03
ALKERMES USD 2.49B 157.48M 2025-12
Amgen USD 90.59B 445M 2025-12
AstraZeneca USD 114.02B 59M 2026-03
Bayer EUR 104.54B 331M 2025-12
Biogen USD 29.48B 43.6M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Drreddys Laboratories INR 6.26B 161.9M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Glaxosmithkline GBP 82.34B 102.25M 2025-12
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Merck USD 136.87B 7.32B 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pacira USD 1.26B 32.66M 2025-12
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Phibro Animal Health USD 1.41B 20.03M 2025-12
Prestige Brands USD 3.49B 52.46M 2025-12
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
Sanofi EUR 126.81B 25.48B 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Zoetis USD 15.47B 308M 2025-12